Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

Temporal trends in, and associations of, early-career general practitioner prescriptions of second-line Type 2 Diabetes medications, 2010-2018.

Irena Patsan
Amanda Tapley
Peter Davoren
Alison Fielding
Elizabeth Holliday
Jean Ball
Andrew Davey
Mieke van Driel
Rachel Turner
Katie Mulquiney
Neil Spike
Kristen FitzGerald
Parker Magin

January 2023

IntroductionSecond-line pharmacotherapy for Type 2 Diabetes Mellitus ('diabetes') is necessary for o...

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017

Curtis, HJ
Dennis, JM
Shields, BM
Walker, AJ
Bacon, SCJ
Hattersley, AT
Jones, AG
Goldacre, B

May 2018

Aims UK guidelines for type II diabetes leave the choice of glucose lowering therapies after metform...

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018

Clemens Engler
Marco Leo
Bernhard Pfeifer
Martin Juchum
Di Chen-Koenig
Karin Poelzl
Hans Schoenherr
David Vill
Juliana Oberdanner
Egon Eisendle
Klaus Middeldorf
Bernhard Heindl
Hannes Gaenzer
Gerald Bode
Karl Kirchmeyr
Guenther Ladner
Lisa Rieger
Ursula Koellensperger
Andrea Schwaiger
Florian Stoeckl
Guenther Zangerl
Monika Lechleitner
Irmgard Delmarko
Wilhelm Oberaigner
Clemens Rissbacher

April 2020

Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

Hattersley, Andrew
Shields, Beverley M.
Jones, Angus G

March 2019

Aim To describe population‐level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010–2017

Dennis, John M.
Henley, William E.
McGovern, Andrew P.
Farmer, Andrew J.
Sattar, Naveed
Holman, Rury R.
Pearson, Ewan R.
Hattersley, Andrew T.
Shields, Beverley M.
Jones, Angus G.

July 2019

Aim: To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, ...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010–2017

Dennis, J
Henley, W
McGovern, A
Farmer, A
Sattar, N
Holman, R
Pearson, E
Hattersley, A
Shields, B
Jones, A

January 2019

Aim: To describe population‐level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors:a retrospective analysis of primary care data, 2010-2017

Dennis, John M.
Henley, William E.
McGovern, Andrew P.
Farmer, Andrew J.
Sattar, Naveed
Holman, Rury R.
Pearson, Ewan R.
Hattersley, Andrew T.
Shields, Beverley M.
Jones, Angus G.

July 2019

Aim: To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors:a retrospective analysis of primary care data, 2010-2017

Dennis, John M.
Henley, William E.
McGovern, Andrew P.
Farmer, Andrew J.
Sattar, Naveed
Holman, Rury R.
Pearson, Ewan R.
Hattersley, Andrew T.
Shields, Beverley M.
Jones, Angus G.

July 2019

Aim: To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017

Dennis, J
Henley, W
McGovern, A
Farmer, A
Sattar, N
Holman, R
Pearson, E
Hattersley, A
Shields, B
Jones, A

March 2019

This is the author accepted manuscript. The final version is available on open access from Wiley via...

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes." Diabetes Care 26(6

Fredric J. Cohen
Cheryl A. Neslusan
Jonathan E. Conklin
Xue Song Phd

January 2003

OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015

Higgins V
Piercy J
Roughley A
Milligan G
Leith A
Siddall J
Benford M

November 2016

Victoria Higgins, James Piercy, Adam Roughley, Gary Milligan, Andrea Leith,&nbsp...

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.

Lipska, Kasia J
Yao, Xiaoxi
Herrin, Jeph
McCoy, Rozalina G
Ross, Joseph S
Steinman, Michael A
Inzucchi, Silvio E
Gill, Thomas M
Krumholz, Harlan M
Shah, Nilay D

April 2017

ObjectiveTo examine temporal trends in utilization of glucose-lowering medications, glycemic control...

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Montvida, Olga
Shaw, Jonathan
Atherton, John J
Stringer, Frances
Paul, Sanjoy K

November 2017

To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patterns, alon...

Long-term trends in antidiabetes drug usage in the U.S.: Real-world evidence in patients newly diagnosed with type 2 diabetes

Montvida, Olga
Shaw, Jonathan
Atherton, John J.
Stringer, Frances
Paul, Sanjoy K.

January 2018

OJBECTIVE To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patt...

Long-term trends in antidiabetes drug usage in the U.S.: Real-world evidence in patients newly diagnosed with type 2 diabetes

Montvida, Olga
Shaw, Jonathan
Atherton, John J.
Stringer, Frances
Paul, Sanjoy K.

January 2018

OJBECTIVE To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patt...

Temporal trends in, and associations of, early-career general practitioner prescriptions of second-line Type 2 Diabetes medications, 2010-2018.

Irena Patsan
Amanda Tapley
Peter Davoren
Alison Fielding
Elizabeth Holliday
Jean Ball
Andrew Davey
Mieke van Driel
Rachel Turner
Katie Mulquiney
Neil Spike
Kristen FitzGerald
Parker Magin

January 2023

IntroductionSecond-line pharmacotherapy for Type 2 Diabetes Mellitus ('diabetes') is necessary for o...

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017

Curtis, HJ
Dennis, JM
Shields, BM
Walker, AJ
Bacon, SCJ
Hattersley, AT
Jones, AG
Goldacre, B

May 2018

Aims UK guidelines for type II diabetes leave the choice of glucose lowering therapies after metform...

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018

Clemens Engler
Marco Leo
Bernhard Pfeifer
Martin Juchum
Di Chen-Koenig
Karin Poelzl
Hans Schoenherr
David Vill
Juliana Oberdanner
Egon Eisendle
Klaus Middeldorf
Bernhard Heindl
Hannes Gaenzer
Gerald Bode
Karl Kirchmeyr
Guenther Ladner
Lisa Rieger
Ursula Koellensperger
Andrea Schwaiger
Florian Stoeckl
Guenther Zangerl
Monika Lechleitner
Irmgard Delmarko
Wilhelm Oberaigner
Clemens Rissbacher

April 2020

Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

Hattersley, Andrew
Shields, Beverley M.
Jones, Angus G

March 2019

Aim To describe population‐level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010–2017

Dennis, John M.
Henley, William E.
McGovern, Andrew P.
Farmer, Andrew J.
Sattar, Naveed
Holman, Rury R.
Pearson, Ewan R.
Hattersley, Andrew T.
Shields, Beverley M.
Jones, Angus G.

July 2019

Aim: To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, ...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010–2017

Dennis, J
Henley, W
McGovern, A
Farmer, A
Sattar, N
Holman, R
Pearson, E
Hattersley, A
Shields, B
Jones, A

January 2019

Aim: To describe population‐level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors:a retrospective analysis of primary care data, 2010-2017

Dennis, John M.
Henley, William E.
McGovern, Andrew P.
Farmer, Andrew J.
Sattar, Naveed
Holman, Rury R.
Pearson, Ewan R.
Hattersley, Andrew T.
Shields, Beverley M.
Jones, Angus G.

July 2019

Aim: To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors:a retrospective analysis of primary care data, 2010-2017

Dennis, John M.
Henley, William E.
McGovern, Andrew P.
Farmer, Andrew J.
Sattar, Naveed
Holman, Rury R.
Pearson, Ewan R.
Hattersley, Andrew T.
Shields, Beverley M.
Jones, Angus G.

July 2019

Aim: To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, an...

Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017

Dennis, J
Henley, W
McGovern, A
Farmer, A
Sattar, N
Holman, R
Pearson, E
Hattersley, A
Shields, B
Jones, A

March 2019

This is the author accepted manuscript. The final version is available on open access from Wiley via...

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes." Diabetes Care 26(6

Fredric J. Cohen
Cheryl A. Neslusan
Jonathan E. Conklin
Xue Song Phd

January 2003

OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015

Higgins V
Piercy J
Roughley A
Milligan G
Leith A
Siddall J
Benford M

November 2016

Victoria Higgins, James Piercy, Adam Roughley, Gary Milligan, Andrea Leith,&nbsp...

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.

Lipska, Kasia J
Yao, Xiaoxi
Herrin, Jeph
McCoy, Rozalina G
Ross, Joseph S
Steinman, Michael A
Inzucchi, Silvio E
Gill, Thomas M
Krumholz, Harlan M
Shah, Nilay D

April 2017

ObjectiveTo examine temporal trends in utilization of glucose-lowering medications, glycemic control...

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Montvida, Olga
Shaw, Jonathan
Atherton, John J
Stringer, Frances
Paul, Sanjoy K

November 2017

To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patterns, alon...

Long-term trends in antidiabetes drug usage in the U.S.: Real-world evidence in patients newly diagnosed with type 2 diabetes

Montvida, Olga
Shaw, Jonathan
Atherton, John J.
Stringer, Frances
Paul, Sanjoy K.

January 2018

OJBECTIVE To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patt...

Long-term trends in antidiabetes drug usage in the U.S.: Real-world evidence in patients newly diagnosed with type 2 diabetes

Montvida, Olga
Shaw, Jonathan
Atherton, John J.
Stringer, Frances
Paul, Sanjoy K.

January 2018

OJBECTIVE To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patt...

Temporal trends in, and associations of, early-career general practitioner prescriptions of second-line Type 2 Diabetes medications, 2010-2018.

Irena Patsan
Amanda Tapley
Peter Davoren
Alison Fielding
Elizabeth Holliday
Jean Ball
Andrew Davey
Mieke van Driel
Rachel Turner
Katie Mulquiney
Neil Spike
Kristen FitzGerald
Parker Magin

January 2023

IntroductionSecond-line pharmacotherapy for Type 2 Diabetes Mellitus ('diabetes') is necessary for o...

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017

Curtis, HJ
Dennis, JM
Shields, BM
Walker, AJ
Bacon, SCJ
Hattersley, AT
Jones, AG
Goldacre, B

May 2018

Aims UK guidelines for type II diabetes leave the choice of glucose lowering therapies after metform...

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018

Clemens Engler
Marco Leo
Bernhard Pfeifer
Martin Juchum
Di Chen-Koenig
Karin Poelzl
Hans Schoenherr
David Vill
Juliana Oberdanner
Egon Eisendle
Klaus Middeldorf
Bernhard Heindl
Hannes Gaenzer
Gerald Bode
Karl Kirchmeyr
Guenther Ladner
Lisa Rieger
Ursula Koellensperger
Andrea Schwaiger
Florian Stoeckl
Guenther Zangerl
Monika Lechleitner
Irmgard Delmarko
Wilhelm Oberaigner
Clemens Rissbacher

April 2020

Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

Abstract

Extracted data

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017

Abstract

Extracted data

Related items

Related items